Literature DB >> 29180733

Second anticancer CAR T therapy receives FDA approval.

Asher Mullard.   

Abstract

Year:  2017        PMID： 29180733     DOI： 10.1038/nrd.2017.249

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics.

Authors:  Sandhya R Panch; Sandeep K Srivastava; Nasha Elavia; Andrew McManus; Shutong Liu; Ping Jin; Steven L Highfill; Xiaobai Li; Pradeep Dagur; James N Kochenderfer; Terry J Fry; Crystal L Mackall; Daniel Lee; Nirali N Shah; David F Stroncek
Journal:  Mol Ther       Date:  2019-05-30       Impact factor: 11.454

Review 2.  Advancing biotechnology with CRISPR/Cas9: recent applications and patent landscape.

Authors:  Raphael Ferreira; Florian David; Jens Nielsen
Journal:  J Ind Microbiol Biotechnol       Date:  2018-01-24       Impact factor: 3.346

3.  Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model.

Authors:  Marvin M Festag; Julia Festag; Simon P Fräßle; Theresa Asen; Julia Sacherl; Sophia Schreiber; Martin A Mück-Häusl; Dirk H Busch; Karin Wisskirchen; Ulrike Protzer
Journal:  Mol Ther       Date:  2019-02-10       Impact factor: 11.454

4.  Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics.

Authors:  Jennifer A Rohrs; Dongqing Zheng; Nicholas A Graham; Pin Wang; Stacey D Finley
Journal:  Biophys J       Date:  2018-08-22       Impact factor: 4.033

Review 5.  Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?

Authors:  Wei Zhan; Manish Muhuri; Phillip W L Tai; Guangping Gao
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

6.  Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells.

Authors:  L Herrera; S Santos; M A Vesga; J Anguita; I Martin-Ruiz; T Carrascosa; M Juan; C Eguizabal
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.